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ABSTRACT
Biogenesis of messenger RNA is critically influenced
by the phosphorylation state of the carboxy-terminal
domain (CTD) in the largest RNA polymerase II
(RNAPII) subunit. Several kinases and phosphatases
are required to maintain proper CTD phosphoryla-
tion levels and, additionally, several other proteins
modulate them, including Rpb4/7 and Sub1. The
Rpb4/7 heterodimer, constituting the RNAPII stalk,
promote phosphatase functions and Sub1 globally
influences CTD phosphorylation, though its mecha-
nism remains mostly unknown. Here, we show that
Sub1 physically interacts with the RNAPII stalk do-
main, Rpb4/7, likely through its C-terminal region,
and associates with Fcp1. While Rpb4 is not re-
quired for Sub1 interaction with RNAPII complex, a
fully functional heterodimer is required for Sub1 as-
sociation to promoters. We also demonstrate that a
complete CTD is necessary for proper association of
Sub1 to chromatin and to the RNAPII. Finally, genetic
data show a functional relationship between Sub1
and the RNAPII clamp domain. Altogether, our re-
sults indicate that Sub1, Rpb4/7 and Fcp1 interaction
modulates CTD phosphorylation. In addition, Sub1
interaction with Rpb4/7 can also modulate transcrip-
tion start site selection and transcription elongation
rate likely by influencing the clamp function.
INTRODUCTION
Eukaryotic RNA polymerase II (RNAPII) contains 12 sub-
units, Rpb1–Rpb12. Rpb1, the largest subunit, has a unique
and highly conserved carboxy-terminal domain (CTD)with
an essential role in transcription regulation in vivo (1–4).
The RNAPII CTD is required for efficient capping, splic-
ing and cleavage/polyadenylation of pre-mRNAs (5–7). It
recruitsRNAprocessing, export and histonemodifying fac-
tors to the transcription complex, coupling mRNA bio-
genesis to other nuclear processes (3,8). Nearby the CTD
and the RNA exit channel, two RNAPII subunits, Rpb4
and Rpb7, form a heterodimer that protrudes from the en-
zyme core like a stalk. From this location, the Rpb4/7 het-
erodimer regulates the interaction with factors important
for RNA biogenesis, such as several components of the PIC
and the Mediator (9–11), and for CTD modification. In-
deed, we have shown that the Rpb4/7 heterodimer plays a
key role in controlling phosphorylation of the CTD (12).
The CTD is composed of a repeated heptapeptide mo-
tif (26-52 depending upon the organism) with a consensus
sequence of Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7 (13,14).
Five of the seven residues can be phosphorylated, though
Ser2 and Ser5 phosphorylation seem to be the predominant
modifications (5,7,15). In mammals, the CTD can be also
acetylated (16), glycosylated (17,18) and methylated (19).
The multitude of possible CTD modifications, especially
Ser phosphorylations, in combination with the numerous
repetitions, generates a wide range of phosphorylation pat-
terns that have been proposed to comprise a “CTD code”
(20). The CTDmodifications are dynamic and differentially
orchestrate the recruitment of a number of factors required
for transcriptional efficiency and RNA processing (21,22).
Several kinases and phosphatases regulate the levels of
CTD phosphorylation (23). In Saccharomyces cerevisiae,
four cyclin-dependent kinases (CDKs), Srb10, Kin28, Ctk1
and Bur1 (3,7) as well as four phosphatases, Rtr1, Ssu72,
Glc7 and Fcp1 (23,24) determine CTD phosphorylation
along the transcription cycle. Three additional yeast factors
have been involved in themodulation of CTDphosphoryla-
tion: Ess1, Sub1 andRpb4/7 (12,25,26). The peptidyl prolyl
cis–trans isomerase Ess1 promotes the function of Ssu72 by
isomerising CTD prolines in yeast, while human Pin1 iso-
merase assists Fcp1 activity (26–28).More recently, we have
shown that Rpb4/7 heterodimer is important for recruiting
Ssu72 and Fcp1 phosphatases (12). Sub1 globally modu-
lates CTD phosphorylation all along the transcription cycle
(25) although its mechanism remains essentially unknown.
Sub1 was originally identified as a transcriptional stimula-
tory protein, homologous to the human positive coactiva-
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tor PC4 (29–33) that physically interacts with TFIIB, ar-
guing for a role as a coactivator in transcription initiation
(34,35). Indeed, Sub1 has been identified as a component
of the pre-initiation (PIC) complex (36), and having a role
in the selection of transcription start site (TSS) (37). Ad-
ditionally, Sub1 has also been implicated in other aspects
of mRNA biogenesis, such as elongation (38), transcription
termination, and 3′end formation (39–41). Here, we present
novel data demonstrating that Sub1 directly interacts with
the Rpb4/7 heterodimer via Rpb7 and, in association with
Fcp1, modulates the CTD phosphorylation levels. More-
over, our data suggest a role for Sub1 related to the Rpb1
clamp domain, in agreement with the role of Sub1 in the
transcription start site (TSS) selection and in the regulation
of the RNAPII transcription rate and its interaction with
the elongation factor Spt5 (38).
MATERIALS AND METHODS
Yeast strains and media
The strains used are listed in Table 1 (Supplementary data).
Strain construction and other genetic manipulations were
performed following standard procedures (42). Oligonu-
cleotide sequences are available upon request.
TAP purification and mass spectrometric analysis
Purification of Sub1–TAP was performed as described in
(43). Sub1–TAP and associated proteins were recovered
from cell extracts by affinity selection on an IgGmatrix. Af-
ter washing, TEV protease was added to release the bound
material. The eluate was incubated with calmodulin-coated
beads in the presence of calcium. After washing, the bound
material was released by incubation with EGTA. The eluate
was analyzed by Nano-ESI ion-trap mass spectrometry, or
by trichloroacetic acid precipitation and analyzed by West-
ern blotting.
Co-immunoprecipitation and western blot analysis
Cells containing TAP-tagged Sub1, and HA-tagged
Rpb4/Rpb7 were grown in 200 ml of rich medium to
an OD600 of 1.0, harvested, washed with water, followed
by suspension in 2.5 ml of lysis buffer (20 mM HEPES
pH 7.6, 200 mM potassium acetate, 1 mM EDTA pH
8.0, glycerol 10 %) containing protease and phosphatase
inhibitors. The cell suspension was flash frozen in liquid
nitrogen, and then ground in a chilled mortar to a fine
powder. Afterwards, the cell lysate was thawed slowly on
ice and transferred to pre-chilled tubes and centrifuged
at 13 200 rpm for 20 min. The supernatant was collected
and total protein concentration was estimated measuring
absorbance at 280 nm in a nanodrop. In experiments where
Sub1–TAP was precipitated, the volume of each cell extract
containing 25 mg of protein was incubated with 50 l of
IgG Sepharose 6FF (GE Healthcare) slurry for 2 h at 4◦C.
In experiments where Rpb3 was immunoprecipitated, cell
extracts were incubated with 5 l of anti-Rpb3 antibody
for 2 h at 4◦C, followed by binding to 30 l of Protein
A Sepharose CL-4B (GE Healthcare) for another 2 h at
4◦C. The IPs were extensively washed with lysis buffer
and beads were suspended in SDS-PAGE sample buffer.
Thereafter they were incubated at 65◦C for 20 min and
supernatants were loaded onto a SDS-PAGE gel. In the
case of Rpb3 IP in whole cell extracts from wt and rpb4,
and wt and rpb1-CTD11 cells containing Sub1–TAP, we
proceeded similarly, except that cell lysis was achieved at
4◦C using a FastPrep System and 5 mg of total protein was
immunoprecipitated. This was also the procedure used to
IP Sub1–HA to study Fcp1-MYC/Sub1–HA association.
In addition, RNase A and DNAse I treatments were done
by incubating washed beads in lysis buffer with 10 mg/ml
RNase A at room temperature for 15 minutes or with 10
units/l DNAse I for 20 min at 37◦C in its own buffer.
Western blot analysis was performed using the appropri-
ate antibodies in each case. Anti-phosphoglycerate kinase
(Pgk1, 459250; Invitrogen), anti-HA (12CA5, Roche); anti-
TAP (CAB1001, Open Biosystems); anti-Rpb1: Y-80 (sc-
25758, Santacruz) and 8WG16 (8WG16 (nonP-CTD, Co-
vance); anti-Rpb4 (2Y14; Santa Cruz); anti-Rpb3 (1Y26;
Santa Cruz); anti-MYC (9E10, Santa Cruz) were acquired
from the indicated vendors. The ECL reagents were used
for detection. The signal was acquired on film and/or with
a ChemiDoc XRS (Bio-Rad) system and when necessary
quantified with the Quantity One software (Bio-Rad).
Expression and purification of recombinant proteins
Recombinant Sub1.
Transfection, virus amplification and protein expression.
Sub1 recombinant bacmid was transfected into adherent
High Five™ insect cells (Invitrogen). For virus amplifica-
tion, recombinant baculovirus stocks were used to infect
insect cells for four days. The amplified virus stock (25 ml)
was obtained by cell pipetting and centrifugation at 2000
rpm for 5 min and then stored at 4◦C. For protein expres-
sion, the virus amplification procedure was followed except
that the flasks containing adherent insect cells were infected
eachwith 70l of the amplified virus stock. Finally, the cells
were harvested and frozen.
Purification. Frozen cell pellets were thawed and resus-
pended in lysis buffer (100 mM Tris pH 7.4, 300 mMNaCl,
6 mM MgCl2, 10% (v/v) glycerol, half tablet of EDTA-
free Protease Inhibitor Cocktail (Complete™, Roche) and
DNase I (Roche)). Cells were sonicated, centrifuged and
the supernatant loaded into a HisTrap HP (GE Health-
care) affinity chromatography column equilibrated in bind-
ing buffer (100 mM Tris pH 7.4, 300 mM NaCl, 10% (v/v)
glycerol). The column was extensively washed with HTA
buffer (100 mMTris pH 7.4, 300 mMNaCl, 10% (v/v) glyc-
erol, 20 mM Imidazole) and washing buffer (100 mM Tris
pH 7.4, 1.5MNaCl, 10% (v/v) glycerol, 20mM Imidazole),
and then re-equilibrated in HTA buffer. Protein was eluted
by running a gradient from 0% to 100% HTB buffer (100
mM Tris pH 7.4, 300 mM NaCl, 10% (v/v) glycerol, 250
mM imidazole) in 20 column volumes and collected frac-
tions were analyzed by SDS-PAGE. Selected fractions were
pooled, concentrated in a 10 kDa cut-off centrifugal filter
(Millipore) and loaded onto a Superdex 200 10/300 GL
(GEHealthcare) column equilibrated in GF buffer (20 mM
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Tris pH 7.4, 100 mM NaCl). The fractions containing the
eluted protein were collected and analyzed by SDS-PAGE.
The concentrated pool of the fractions containing the pro-
tein was frozen in liquid nitrogen and stored at −80◦C.
To eliminate the His6-tag at the C-terminus, the protein
was incubated with TEV protease (ratio Sub1:TEV 1:50)
overnight at 4◦C in a mixture containing 1 mM DTT. Di-
gestion was confirmed by SDS-PAGE given the different
electrophoretic mobilities of the His-tagged and untagged
proteins. The digested protein was purified by recovering it
from the supernatant after incubation of the reaction mix
with a Ni resin (Ni Sepharose High Performance, Amer-
shamBiosciences), where both undigested protein and TEV
protease were captured through their polyhistidine tails.
Fractions containing the digested protein were pooled and
concentrated using Millipore centrifugal devices.
rRpb4/Rpb7-6His
We co-expressed and purified Rpb4/7 complex as described
(44) from a plasmid containing Rpb4 and Rpb7, where a
six-histidine tail was fused to the C-terminus of Rpb7.
Pull down-assays
Recombinant Rpb4/Rpb7-6His proteins (3 g) were incu-
bated in a 20 l slurry of HisPur Cobalt Resine (Thermo
Scientific) in binding buffer (20 mM Tris pH 7.5, 50 mM
NaCl) for 2 h at 4◦C. Thereafter, the resin with attached
Rpb4/Rpb7-6His was washed three times with binding
buffer and then Sub1 (3 g) was added and incubated with
the resin for 3 more hours at 4◦C in binding buffer. As a
negative control, the same amount of Sub1 was incubated
in parallel under the same conditions with 20 l slurry of
Cobalt resin without Rpb4/7 proteins. After incubation,
the resin was washed four times with washing buffer (20
mM Tris pH 7.5, 100 mM NaCl) and then treated with 15
l of elution buffer (20 mM Tris pH 7.5, 100 mM NaCl,
150 mM imidazole) for 5 minutes at room temperature. The
eluate was collected and analysed by SDS-PAGE. The gel
was stained by immersion into Blue Safe staining solution
(NZY tech) for several hours.
Chromatin immunoprecipitation (ChIP)
Chromatin purification, immunoprecipitation, quantitative
real-time PCR (qPCR) amplification and data analysis were
performed as described (12,25,45). Briefly, PCR of purified
chromatin, following immunoprecipitation, was performed
by quantitative real-time PCR with the CFX96 Detection
System (Bio-Rad Laboratories, Inc.), using SsoAdvanced™
Universal SYBR® Green Supermix (Bio-Rad) following
the manufacturer’s instructions. Four serial 10-fold dilu-
tions of genomic DNA were amplified using the same re-
action mixture as the samples to construct the standard
curves. Real-time PCR reactions were performed in tripli-
cate using at least three independent ChIPs. Quantitative
analysis was carried out using the CFX96 Manager Soft-
ware (version 3.1, Bio-Rad). The values obtained for the
IP’d PCR products were compared to those of the total in-
put, and the ratio of the values from each PCRproduct from
transcribed genes to a non-transcribed region of chromo-
some VII was calculated. Numbers on the y-axis of graphs
are detailed in the corresponding figure legend.
RNA isolation and RT-PCR
Total RNA was extracted as described (46) and RT-PCR
was performed using the iScript RT reagent Kit (Bio-Rad),
following the manufacturer’s instructions. PCR reactions
were performed in triplicate with at least three independent
cDNA samples.
Sub1 mutagenesis
The sub1-FRN54-56AGG triple mutation was generated
by site-directed mutagenesis of a wild-type copy of SUB1
cloned into a centromeric plasmid under the control of its
own promoter and with a 6x-HA epitope at the C-terminus
of the protein. Plasmid expressing the ssDNA binding do-
main mutation or a wt copy of SUB1was used to transform
the sub1Δ mutant and to generate the sub1-FRN54-56AGG
strain. As a control, the sub1Δ strain was transformed with
an empty plasmid.
RESULTS
Sub1 interacts with RNAPII through the Rpb4/7 het-
erodimer
Sub1 influences RNAPII CTD phosphorylation via all four
CTD kinases: Kin28, Srb10, Bur1 and Ctk1 (25). This
was observed both genetically and biochemically, including
Sub1 effects on kinase activity and/or recruitment to chro-
matin. Thus, Sub1 can act throughout the transcription cy-
cle as a general regulator of CTD phosphorylation, though
we do not understand the biochemical basis of the influence
of Sub1 on the activity of all four CTD kinases. We consid-
ered two possible explanations: (i) Sub1 enhances the asso-
ciation (or dissociation) of an unidentified, common regu-
lator with the kinases; or (ii) Sub1 influences kinase acces-
sibility to the CTD.
To further explore the first possibility, we decided to
analyse the repertoire of Sub1 physical interactions us-
ing the TAP strategy (43). Accordingly, Sub1 was TAP-
tagged and associated proteins were MS-analysed. We
found among other proteins Spt5, consistent with previous
work (38,47). More interestingly, we identified the Rpb7
subunit of RNAPII as a co-purifying protein. This dis-
covery is extremely interesting since Rpb7, together with
Rpb4, is near the CTD, and the heterodimer Rpb4/7
has been functionally related with CTD phosphorylation
(12). To corroborate the specificity of Sub1-Rpb7 asso-
ciation, we purified Sub1–TAP complexes in a double
tagged strain, Sub1–TAPRpb7–HA, and analyzed the TAP
purified complex by western blot using the correspond-
ing antibodies to visualize Sub1 and Rpb7 (Figure 1A).
We confirmed Sub1–TAP/Rpb7–HA association by co-
immunoprecipitation (Co-IP), and demonstrated that Sub1
also associates with Rpb4, using a tripled tagged strain
Sub1–TAP Rpb7–HA Rpb4–HA (Figure 1B). These data
indicate that Sub1 associates with the Rpb4/7 heterodimer.
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Figure 1. Sub1 interacts with the RNAPII through the Rpb4/7 heterodimer. (A) Sub1 tandem affinity purification from Sub1–TAP and Sub1–TAPRpb7–
HAwhole cell extracts (WCE). Input and the purified proteins were precipitated with trichloroacetic acid and analyzed by western blotting using anti-TAP
and anti-HA. Anti-Pgk1 was used as a loading control. (B) Co-IP performed using WCEs from Sub1–TAP (Rpb7–HA and Rpb7–HA/Rpb4–HA) with
IgG Sepharose. Input and IPs were analyzed by western blotting with antibodies to the indicated proteins.
Allelic specific interaction between SUB1 and RPB4/7
To gain more insight into the functional connection be-
tween Sub1 and the RNAPII stalk heterodimer, we ana-
lyzed genetic interaction between SUB1 and RPB4/7. As
Rpb7, but not Rpb4, is essential for cell viability we worked
with the rpb4Δ mutant that displays slow growth at 28◦C
and thermosensitivity at 37◦C (48,49). Deletion of SUB1
partially suppresses the rpb4Δ growth defects at 28 and
34◦C, but does not suppress rpb4Δ thermosensitivity at
37◦C (Figure 2A). On the other hand, overexpression of
SUB1 using a strong constitutive or inducible promoter
(ADH1 andGAL1, respectively; Figure 2A and Supplemen-
tary Figure S1A), dramatically reduces rpb4Δ cell growth.
In addition, we used an Rpb7-TAP strain where the C-
terminal Rpb7-TAP tag causes growth defects (Supplemen-
tary Figure S1B). In this case, the growth defects at 28 and
34◦C are also partially rescued by SUB1 deletion (Supple-
mentary Figure 1B). Therefore, SUB1 genetically interacts
with RPB4 and RPB7, in agreement with the association
of Sub1 with the Rpb4/7 heterodimer (Figure 1). How-
ever, this genetic result was unexpected, because deletion
of SUB1 mostly displays negative genetic interactions with
mutations compromising transcription initiation and elon-
gation, for instance mutations in TFIIB, TFIIE, TFIIH,
Kin28, Ctk1, Bur1, Fcp1, Spt5/Spt4 (25,36,38,41,50). The
positive genetic interaction between SUB1 and RPB4 and
RPB7 suggests that Sub1 may be gaining a function when
the heterodimer function is altered.
To investigate the specificity of this interaction, we an-
alyzed the genetic interaction between SUB1 and RPB1.
For that purpose we choose three rpb1 alleles. Two of them
are functionally and structurally related toRpb4/7, rpo21-4
and rpb1-L1397S, which are localized in the foot and clamp
domains, respectively (51,52); and a third one, rpb1-19, is lo-
calized in the jaw domain (53), far from Rpb4/7 within the
context of RNAPII complex (54).
The foot domain is a conserved region of RNAPII lo-
cated at the surface of the complex, with poor or no con-
servation in their paralogs, Rpa190 (RNAPI) and Rpc160
(RNAPIII), or in their homologs in archaea and bacteria
(55,56). The foot domain is crucial for the assembly and
stability of RNAPII, by ensuring the correct association of
Rpb1 with Rpb6 andRpb4/Rpb7. In fact, assembly defects
alter not only transcriptional activity but also RNAPII-
DNA association and CTD phosphorylation (51). Thus,
we used the rpo21-4 (rpb1-W954-LELE-955) foot mutant
(57,58) where the association of the Rpb4/7 heterodimer
with RNAPII is reduced (51). This mutant displays re-
duced growth at 28◦C and exhibits slow growth at 34◦C and
37◦C (Figure 2B). Interestingly, we observed that deletion
of SUB1 suppressed rpo21-4 growth defects at 34 and 37◦C,
whereas sub1Δ does not affect growth at these temperatures
in awtRPB1 background.Hence, rpo21-4 suppression reca-
pitulates the growth defects observed in the double mutant
rpb4Δsub1Δ. These data indicate that sub1Δ suppresses
mutations compromising the function of the Rpb4/7 het-
erodimer, either by deletion of RPB4 or by a mutation on
the Rpb1 foot domain.
The RNAPII clamp is a flexible structural element pos-
tulated to intervene in the regulation of DNA access to
the cleft (59). An open clamp is observed in the absence
of the Rpb4/7 heterodimer (56), while the complete en-
zyme presents a closed clamp conformation (54). Rpb4/7
plays a role in the mobility of this domain during tran-
scription initiation (60,61). Therefore, we studied whether
a sub1Δ deletion might genetically interact with the rpb1-
L1397S clamp mutation. Specifically, this amino acid sub-
stitution occurs in the Rpb1 -47b helix of the Switch 1
loop of the catalytic site within the structure of theRNAPII.
In fact, the Switch 1 loop holds the DNA template strand
at position +2/+3 downstream of the catalytic Mg2+ (62).
The rpb1-L1397S mutant displays slow growth at 28◦C,
cold and thermosensitivity and reduced RNAPII associa-
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Figure 2. Allelic specific interaction between SUB1 and RPB4/7. (A) Ge-
netic interaction between SUB1 and RPB4. SUB1 deletion partially sup-
presses the slow growth phenotype of the rpb4 strain at 28 and 34◦C,
while overexpression of SUB1 exacerbates it. SUB1 was overexpressed
from a strong constitutive ADH1 promoter. Serial dilutions (1:10) of wt
and mutant strains were spotted on selective SC media and grown for 2–3
days at the indicated temperatures. (B) Genetic interaction between SUB1
and the rpo21-4 mutation localized in the Rpb1 foot domain. Deletion of
SUB1 partially suppresses the slow growth phenotype of rpo21-4 strain at
28, 34 and 37◦C. Cells were assayed as in (A) in rich media. (C) sub1Δ and
rpb1-L1397S are synthetically lethal. A diploid yeast strain heterozygous
for both SUB1 and rpb1-L1397S was sporulated and the meiotic progeny
were separated by tetrad dissection, and allowed to grow for 3 days. Forty-
six tetradswere dissected, with thirty showing tetratype segregation pattern
(TT, five of which are shown), nine showing paternal ditype (PD) and 7 a
nonpaternal ditype (NPD). The genotype of the resulting colonies was in-
ferred by growth or no growth on selective medium and 37◦C. The sub1Δ
deletion is indicated as (−), andwt (+); and in the case ofRPB1, (+) means
rpb1-L1397S and (−) wt. Cells deleted for rpb1-L1397S alone (− −) show
a slow growth phenotype, as reported previously. Double mutants cells (−
+) were unviable. (D) There is not genetic interaction between sub1Δ and
the rpb1–19mutation on the jaw domain of Rpb1. Serial dilution assay as
in (B) showing that single and double mutants, rpb1–19 and rpb1-19sub1Δ
respectively, display similar growth.
tion with genes (52). Both, rpb1-L1397S and sub1Δ show
upregulation of IMD2 transcription (38,52), which is a hall-
mark of defects on TSS selection (63). Indeed, it has been
shown that Sub1 participates in TSS selection (37). We then
crossed the rpb1-L1397S mutant with the sub1Δ deletion
mutant. The diploid cells were sporulated and the tetrads
dissected. Interestingly, sub1Δ conferred synthetic lethality
in combination with rpb1-L1397S (Figure 2C). This could
be explained as a result of the additive effect of both muta-
tions, sub1Δ and rpb1-L1397S, reducing RNAPII gene oc-
cupancy during transcription to levels that may be incom-
patible with cell viability (41,45,52). Also, synthetic lethal-
ity may be the result of the combined defect on elongation
(38,64,65), and/or on the TSS selection (37,52). In any case
and importantly, this result shows the essentiality of Sub1
in a context where the clamp function is impaired.
We also tested the effect of SUB1 deletion on the rpb1-
19 jaw mutant. In this case no genetic interaction was ob-
served (Figure 2D). As noted above, this domain is situ-
ated far fromRpb4/7within theRNAPII structure (54). All
of these data indicate an allele-specific interaction between
sub1Δ and mutations localized within or proximal to the
Rpb4/7 heterodimer in the context of the RNAPII 10 sub-
unit complex. In addition, they corroborate the specificity
of a functional relationship between Sub1 and the Rpb4/7
heterodimer consistent with their physical association (Fig-
ure 1).
A functional Rpb4/7 heterodimer is a requisite for Sub1 re-
cruitment to gene promoters
We next asked if Sub1 association with promoter DNAwas
affected in rpb4Δ cells, because in these cells Rpb7 levels
are significantly reduced, along with diminished associa-
tion of RNAPII with DNA (66–68). Thus, we performed
chromatin immunoprecipitation (ChIP) using the wt and
rpb4Δ Sub1–HA tagged strains, where in addition to Sub1,
we also analyzed Rpb1 and Rpb3 occupancy at the pro-
moters of several constitutively transcribed genes. In agree-
ment with published data (12), Rpb4 is required for proper
RNAPII occupancy to gene promoters as inferred from re-
duced Rpb1 and Rpb3 association levels (Figure 3A, left
and middle panel, respectively). Interestingly, Sub1 occu-
pancy was also dramatically decreased in rpb4Δ cells. Thus,
<20% of Sub1 was associated with chromatin in cells lack-
ing Rpb4 (Figure 3A, right panel). To determine if this
was simply a consequence of reduced RNAPII occupancy,
we calculated Sub1/Rpb1 and Sub1/Rpb3 ratios, and ob-
served that this was not the case, because the levels of Sub1
association with chromatin were even lower than those of
Rpb1 and Rpb3 (Figure 3B). We observed that these ef-
fects on chromatin association are not due to diminished
Sub1–HAprotein levels, as they are unaltered in rpb4Δ cells
(Figure 3C). Although we did not know whether Sub1 di-
rectly interacts with Rpb7 and/or Rpb4, it is possible that
reducedRpb7 levels in rpb4Δ cells (Figure 3D, and (66–68))
could account for the Sub1 defect on promoter association.
We also tested Sub1–TAP association with chromatin in the
clamp mutant, rpb1-L1397S.No effect was observed: Sub1
was properly detected at gene promoters in the mutant cells
(Figure 3E, left panel) with no change in Sub1–TAP levels
(Figure 3E, right panel).
In conclusion, our data indicate that a functional Rpb4/7
heterodimer is required for Sub1 association with gene pro-
moters. It has been suggested that Sub1, together with
TFIIB, functions in the recruitment of RNAPII to consti-
tutively transcribed genes. Hence, the reduced level of Sub1
bound to promoters in rpb4Δ cells is likely not due to re-
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Figure 3. A functional Rpb4/7 heterodimer is a requisite for Sub1 recruitment to gene promoters. (A) Chromatin immunoprecipitation (ChIP) analyses
were performed using wt and rpb4 strains. Left panel: Rpb1 binding to the promoter (P) of four constitutively expressed genes,ADH1, PGK1, PMA1 and
YEF3 was examined by qPCR. Results were quantified (see Materials and Methods), and relative Rpb1 binding in rpb4 cells is plotted relative to that in
wt cells (set equal to 100). The data plotted correspond to mean values from at least three independent experiments, and the error bars represent standard
deviations. Middle and Right panels show relative Rpb3 and Sub1–HA binding, respectively, plotted as for Rpb1. (B) Plots of Sub1–HA/Rpb1, Sub1–HA
/Rpb3 ratios in wild-type (wt) and rpb4 using data from Figure 1A. (C) Whole cell extracts (WCE) were prepared from wild-type (wt) and rpb4 strains
expressing Sub1–HA and analyzed by western blotting using the following antibodies: anti-HA, anti-Rpb1 (8W16G), anti-Rpb3, anti-Rpb4 (2Y14) and
anti-Pgk1 as a control for total protein. (D) Whole cell extracts (WCE) were prepared from wild-type (wt) and rpb4 strains expressing Rpb7–HA and
analyzed by Western blotting using anti-HA, anti-Rpb4 and anti-Pgk1. (E) Left panel: ChIP analysis in wt and rpb1-L1397S cells as in (A) to analyze
Sub1–TAP occupancy at the promoter (P) of three constitutively expressed genes (PMA1, ADH1 and PGK1) and to the promoter of the IMD2 inducible
gene, whose expression is regulated by Sub1 (38,82), and is upregulated in the rpb1-L1397S mutant (52). Right panel: WCE were prepared from wild-type
(wt) and rpb1-L1397S strains expressing Sub1–TAP and analyzed by Western blotting using anti-TAP and anti-Pgk1 as loading control.
duced RNAPII recruitment. Rather, it is more likely that
Sub1 cannot be maintained stably associated to the DNA,
and/or disassociates faster from the promoter, in the ab-
sence of the Rpb4/7 heterodimer.
Sub1 associates with the Rpb4/7 heterodimer via direct inter-
action with Rpb7
We next proceeded with in vitro assays to investigate
whether the Rpb4/7-Sub1 interaction may be direct. For
that purpose we carried out pull down assays using recom-
binant Sub1 and Rpb4/7 proteins. As shown in Figure 4A,
Sub1 remains associated with Rpb4/7 after extensive wash-
ing, indicating that it directly interacts with the heterodimer.
This result demonstrates for the first time that Sub1 inter-
acts directly with the RNAPII complex. However, we did
not know the direct target of Sub1: Rpb7, Rpb4 or both.
To identify the direct target of Sub1, we co-
immunoprecipitated Sub1–TAP and Rpb7–HA using
whole cell extracts from a wt strain expressing Rpb4–HA
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Figure 4. Sub1 associates with the Rpb4/7 heterodimer via direct interaction with Rpb7. (A) Pull down assay. 15% SDS-PAGE gel showing bands corre-
sponding to recombinant proteins rSub1 and rRpb4/Rpb7-6His. (lanes 2 and 3, respectively) and pull down assays where rSub1 and a Co2+ resin have been
incubated in the absence (lane 4) and in the presence of rRpb4/Rpb7-6His (lane 5). (B) Co-IP performed with IgG Sepharose using WCEs from wt strains
expressing Sub1–TAP and Rpb7–HA/Rpb4–HA and from rpb4Δ cells expressing Sub1–TAP and Rpb7–HA. Input and IPs were analyzed by Western
blotting with antibodies to the indicated proteins. (C) Co-IP performed on WCEs from Sub1–TAP cells (wt and rpb4) using anti-Rpb3 antibody. As a
control, the same amount of cell extracts was incubated only with Protein A sepharose. Inputs and IPs were analyzed by Western blotting with antibodies
to the indicated proteins.
or from the rpb4Δ strain, and analyzed its association by
western blot to determine the contribution of Rpb4 to
Sub1 interaction with the heterodimer. Surprisingly, we
observed that Sub1 still interacts with Rpb7 when lacking
Rpb4 (Figure 4B). In fact, the interaction between Sub1
and Rpb7 is similar in isogenic RPB4 wt and rpb4Δ cells,
though Rpb7–HA levels are reduced in the absence of
Rpb4 as previously described (66–68). Therefore, from all
these data we conclude that the target of Sub1 is Rpb7, in
agreement with identifying only Rpb7 in the Sub1–TAP
purifications (Figure 1A). This result also supports our
conclusion that reduced association of Sub1 to chromatin
in rpb4Δ cells is due to decreased Rpb7 levels (Figure
3A, D). In summary, our data clearly demonstrate that
Sub1 interacts with Rpb4/7 and indicate that this inter-
action could explain how Sub1 is able to modulate CTD
phosphorylation.
Additionally, we tested if Sub1 association with the core
polymerase is influenced by Rpb4. For that purpose we im-
munoprecipitated Rpb3 from wt and rpb4Δ whole cell ex-
tracts expressing Sub1–TAP, and analyzed Sub1 association
by western blot. As shown in Figure 4C, Sub1–TAP asso-
ciates with RNAPII in the absence of Rpb4. Therefore, our
results indicate that Sub1 targets Rpb7 to be associatedwith
the RNAPII, though we cannot exclude that it can also in-
teract with other RNAPII subunits. On the other hand, and
consistent with sub1Δ suppression of rpb4Δ (Figure 2A and
Supplementary Figure S1A), Sub1 may have a negative ef-
fect during transcription when interacting with Rpb7 in the
absence of Rpb4.
Sub1 carboxy-terminal region is important for the functional
interaction with Rpb4/7
Sub1 is a 292-residue polypeptide showing strong similarity
to its human homolog PC4 (127 amino acids) over a 65-
residue region (amino acids 41–105) that includes a single-
stranded DNA binding domain (DBD) and sequences es-
sential for co-activator function (33,34,69). Although Sub1
is highly related to PC4, yeast Sub1 is much larger than
human PC4 (33 KDa versus 15 KDa (34,35,39). Specifi-
cally, Sub1 has an extra carboxy-terminal (CT) region of
∼190 amino acids with unknown function(s), suggesting
that Sub1 might have functional differences from PC4 due
to this additional domain. Like PC4, Sub1 has the capacity
to tightly bind melted DNA and single-stranded DNA in
vitro (34) and both have been implicated inDNA-dependent
processes other than transcription, such as DNA repair and
replication (69–72).
To explore which Sub1 region is involved in Rpb4/7 in-
teraction, we investigated the importance of the Sub1 CT
region and DNA-binding domain (DBD) relative to its in-
teraction with Rpb4/7. For that purpose, two mutants were
generated: (i) a strain where the chromosomal CT region
of Sub1 (from amino acid 105 to stop) was substituted
by a 6xHA epitope; and (ii) a triple-mutant, sub1-FRN54-
56AGG, which encodes Phe54 → Ala, Arg55 → Gly and
Asn56 → Gly replacements. Mutations in the correspond-
ing residues in PC4 (Phe77, Lys78 and Lys79) severely af-
fected the binding of PC4 to ssDNA in vitro (33). Protein ex-
pression of all the mutants was confirmed by western blot
(Supplementary Figure S2A, upper panel). As shown, the
levels of the Sub1CT-HA protein are very low compared
to that of Sub1 levels in the isogenic wt and sub1-FRN54-
56AGG cells, and this effect is not due to defective transcrip-
tion (SupplementaryFigure S2A, lower panel). In sub1ΔCT
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cells, where Sub1 contains only the DNA binding domain,
the protein becomes very unstable.
We next analyzed the association of Sub1–HA with
the promoters of several constitutively transcribed genes
(PMA1, PGK1, PYK1), and with the promoter of the Sub1
target gene IMD2, in normal growth conditions (Figure
5A). For that purpose, we performedChIP assays first inwt,
and sub1ΔCT expressing Sub1–HA and Sub1CT-HA, re-
spectively (Figure 5A, left panel). As expected, Sub1–HA
was efficiently recruited to the promoter of all of genes
tested in wt cells. However, unexpectedly and very inter-
estingly, Sub1 association was either unaffected or only
slightly affected in sub1ΔCT cells (Figure 5A, left panel),
although Sub1CT-HA protein levels were extremely low
(Supplementary Figure S2A). This result indicates that the
C-terminal domain of Sub1 is not required for Sub1 occu-
pancy of gene promoters, but can contribute to it. Thus, the
CT domain, which is not present in PC4, might be involved
in other functions, such as the regulation of Sub1 binding
to the DNA and/or in the interaction with other factors.
In contrast, and as expected, Sub1 association was almost
abolished in sub1-FRN54-56AGG cells (Figure 5A, right
panel), which is consistent with the importance of these
residues for PC4 DNA binding capacity and with the clear
homology between Sub1 and PC4 in the DBD (33,69,73).
We further tested the genetic interaction between RPB4
and the Sub1 CT region and Sub1 DBD. Interestingly, dele-
tion of the Sub1 CT region in rpb4Δ cells rescues their
growth defects at 28 and 34◦C (Figure 5B), recapitulating
the effects of the SUB1 complete deletion (see Figure 2A).
In contrast, no effect was observed when the SUB1 DBD
mutation was expressed in the rpb4Δ sub1Δ cells (Figure
5C, Supplementary Figure S2B). Thus, it is likely that Sub1
may need theCT region to interact withRpb4/7 upon its as-
sociation to promoters through the DBD. This agrees with
some decrease of Sub1 crosslinking at the promoters in the
absence of the CT region (Figure 5A, left panel). If our hy-
pothesis is correct, we should observe that association of
Sub1CT-HAwith gene promoters decreases when lacking
RPB4. Indeed, this is what we observed when we performed
ChIP assays in sub1ΔCT-HA and sub1ΔCT-HA rpb4Δ cells
(Figure 5D). Sub1CT-HA association with the gene pro-
moters is significantly reduced in rpb4Δ cells. Though this
reduction (∼60–50%) is lower than the one observed for
Sub1–HA wt in the absence of Rpb4 (∼80%, Figure 3A),
it supports our idea that Sub1-CT region may interact with
Rpb4/7 to be stably associated with the chromatin. More-
over, our data corroborate the genetic interaction between
SUB1 and RPB4 and offer insight into the function(s) of
Sub1 CT region, which has not been identified previously.
Sub1 and Fcp1 are components of the same complex
Several facts suggested that Sub1 and Fcp1 interact, at least
as part of the same complex where the heterodimer Rpb4/7
is present. First, we reported that Sub1 is a regulator of
Fcp1 and our data indicated that a function of Sub1 is to
facilitate accumulation of Fcp1, likely by directly or indi-
rectly increasing its stability. Additionally we showed that
Fcp1 crosslinking to DNA was significantly reduced in the
sub1Δ strain, with comparable reductions at both 5′ coding
and terminator regions (41). Second, a number of findings
suggested that Rpb4/7 might recruit Fcp1 to regulate CTD
modifications, among them our more recent work show-
ing that Fcp1 association to chromatin is impaired during
the entire transcription cycle in the absence of Rpb4 (12).
Furthermore, in vitro binding and yeast two-hybrid assays
in S. pombe and D. melanogaster, respectively, showed that
Rpb4 interacts with Fcp1 (74,75). Structural and biochemi-
cal studies also suggest that in S. cerevisiae Fcp1 might also
interact with RNAPII through Rpb4/7 (76). Third, here we
have clearly shown that Rpb4/7 interact with Sub1.
To investigate if Sub1 and Fcp1 interact, we performed
CoIPs assays. We detected Fcp1-MYC by IP of Sub1–
HA (Figure 6A). Furthermore, CoIPs assays showed that
Sub1-Fcp1 interaction is resistant to treatment with either
DNAse I or RNAse A, and only strong washing conditions,
such as high salt (500 mM NaCl), weakened their associa-
tion (Figure 6B). These data strengthen the conclusion that
Sub1 is functionally related to RNAPII CTD phosphory-
lation and indicates that this function is likely to be exe-
cuted via its interaction with Rpb4/7 and Fcp1. Moreover,
our data uncover the existence of a physical and functional
connection between Sub1, Rpb4/7 and Fcp1 which is im-
portant to maintain proper RNAPII phosphorylation lev-
els, key in the biogenesis of mRNAs.
A full length Rpb1-CTD is required for efficient Sub1 associ-
ation to gene promoters
Our data suggest that Sub1 may regulate CTD phospho-
rylation through interaction with Rpb4/7 and Fcp1, based
on demonstration that Rpb4/7 is required for CTD de-
phosphorylation by CTD phosphatases (12). In addition,
in an extensive genetic interaction network, SUB1 and the
CTD interact (77). This study revealed a number of sig-
nificant genetic interactions as the CTD was progressively
shortened. Indeed a negative genetic interaction between
rpb1-CTD11 (with a CTD containing only eleven heptad
repeats) and the SUB1 deletion was observed. Although
we did not find a direct interaction between Sub1 and the
CTD, we wondered if the CTD, as well as Rpb4/7, may
contribute to Sub1 occupancy at promoters and to its as-
sociation with RNAPII. To answer the question we took
advantage of several CTD truncation mutants containing
11 and 20 repeats (rpb1-CTD11 and rpb1-CTD20), respec-
tively (77). First, we deleted SUB1 in the rpb1-CTD11 mu-
tant to confirm the genetic interaction. As shown in Figure
7A, deletion of SUB1 exacerbates the growth phenotype of
the rpb1-CTD11 cells.We next decided to investigate if Sub1
association to gene promoters was dependent on the length
of the CTD. For that purpose, we TAP tagged Sub1 in the
RPB1-CTD wt, rpb1-CTD11 and rpb1-CTD20 strains and
we analyzed Sub1–TAP occupancy by ChIP in several gene
promoters (Figure 7B and C). Interestingly, the occupancy
of Sub1 in these regions gets worse as the number of CTD
repeats decreases. Thus, in rpb1-CTD11 cells, Sub1 occu-
pancy of gene promoters is significantly diminished when
compared to wt cells (Figure 7B, left panel) and this is not
due to reduced Sub1 levels (Figure 7B, right panel). On
the other hand, in rpb1-CTD20 cells, Sub1 association with
chromatin diminishes only slightly (Figure 7C) compared to
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Figure 5. Sub1 carboxy-terminal region is important for the functional interaction with Rpb4/7. (A) Left panel: Chromatin immunoprecipitation (ChIP)
analyses were performed usingwt and sub1ΔCT-HA strains expressing Sub1–HA. Sub1 binding to the promoter (P) of three constitutively expressed genes,
PMA1, PGK1, PYK1 and the inducible gene IMD2 was examined by qPCR. Results were quantitated (as in figure 3), and relative Sub1–HA binding in
sub1ΔCT-HA cells is plotted relative to that in wt cells (set equal to 100). Right panel, Chromatin immunoprecipitation (ChIP) analyses were performed
usingwt, SUB1 deletion mutant (sub1), and the DNA binding mutant sub1-FRN54-56AGG. (B) Genetic interaction between sub1ΔCT and rpb4Δ. SUB1
deletion partially suppresses the slow growth phenotype of rpb4 strain at 28 and 34◦C in richmedium. Serial dilutions (1:10) ofwt andmutant strains were
spotted on rich medium and grown for 2–3 days at the indicated temperatures. (C) There is no genetic interaction between the ssDNA binding domain of
Sub1 and RPB4. Serial dilutions (1:10) of the indicated strains were spotted on selective SC medium and grown for 2–3 days at the indicated temperatures.
(D) ChIP analyses were performed in wt and rpb4Δ cells expressing Sub1CT-HA protein.
wt cells. Moreover, the effect on Sub1 occupancy dependent
on CTD length is specific for Sub1, as no effect is observed
for Rpb4 and Rpb3 crosslinking in rpb1-CTD11 cells (Fig-
ure 7B).
We next asked if Sub1–TAP association to the RNAPII
was also affected when the CTD has only eleven repeats.
In this case, we performed CoIP assays using wt and rpb1-
CTD11 whole cell extracts (Figure 7D). First, we analyzed
levels of Rpb1 bywestern blot usingwhole cell extracts from
wt, rpb1-CTD11 and rpb1-CTD20 cells. We used two dif-
ferent antibodies: 8WG16 directed against the CTD and
Y-80 that recognizes the N-terminus of Rpb1 (Figure 7B,
right panel and Figure 7C, right panel). We observed that
levels of Rpb1 were significantly decreased in rpb1-CTD11
when analyzed with the 8WG16 antibody, as previously
shown (77) and in agreement with the number of CTD rep-
etitions (11 versus 25–26 in an otherwise wt cell). How-
ever, Y-80 antibody showed increased Rpb1 levels. These
effects were not observed in the rpb1-CTD20 whole cell ex-
tracts, where Rpb1 levels are similar to the wt cells inde-
pendently of the Rpb1 antibody used. We then performed
Co-IP experiments using the anti-Rpb3 antibody, as no dif-
ferences in Rpb3 levels were observed in the isogenic wt
and rpb1-CTD11 cells. Very interestingly, and in agreement
with the ChIP data, there is less Sub1–TAP associated to
the RNAPII in the rpb1-CTD11mutant than in the wt cells
(Figure 7D). These results underscore the conclusion that
Sub1 and the Rpb1-CTD are functionally related, which
support the role of Sub1 in CTD phosphorylation (25). We
conclude that Rpb4/7 and the Rpb1-CTD are important
for Sub1 association with DNA. Furthermore, at least dur-
ing transcription initiation, Sub1 appears to be localized to
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Figure 6. Sub1 and Fcp1 are components of the same complex. (A) Co-IP performed on WCEs from Sub1–HA and Sub1–HA Fcp1-MYC cells using an
anti-HA antibody. Inputs and IPs were analyzed byWestern blotting with antibodies to the indicated proteins (anti-MYC and anti-HA for Fcp1 and Sub1,
respectively). (B) Same as in (A), except that in the fourth IP the beads were washed with lysis buffer containing 500 mM NaCl, and second and third IPs
were treated with DNAse I and RNAse A, respectively.
a region near the CTD and Rpb4/7 of RNAPII. These re-
sults support the conclusion that Sub1 affects clamp func-
tion and modulates CTD phosphorylation throughout the
transcription cycle.
DISCUSSION
The data presented here provide novel insight into how the
transcriptional coactivator Sub1 modulates RNAPII tran-
scription through interaction with Rpb4/7. Our findings
that Sub1 directly interacts with the Rpb4/7 heterodimer,
associates with Fcp1, and is genetically and functionally re-
lated to the CTD, explain how Sub1 modulates RNAPII
phosphorylation, which crucially regulates the biogenesis
of mRNAs. We also provide evidence indicating that Sub1
contributes to RNAPII clamp function elucidating Sub1
role during the transition from the open to the closed com-
plex formation, thus facilitating transcription elongation.
Sub1, as a PIC component, directly interacts with Rpb4/7
We show that Sub1 interacts with Rpb4/7, most likely via
Rpb7 because Sub1 binds RNAPII in the absence of Rpb4
(Figure 4).However, a fully functional heterodimer seems to
be important for Sub1 association with chromatin, as Sub1
crosslinking to gene promoters is significantly reduced in
the rpb4 null mutant (Figure 3). It is likely that the reduced
levels of Rpb7 in the rpb4Δ cells account for Sub1 chro-
matin association defects. The apparent discrepancy be-
tween the CoIP and ChIP experiments suggests that, while
Rpb4 is not required for Sub1 interaction with RNAPII,
a functional Rpb4/7 is necessary for Sub1 to stably asso-
ciate with chromatin after RNAPII recruitment to the PIC.
We propose a model where Sub1 is recruited to RNAPII
through interaction with Rpb4/7, TFIIB (36,50,78) and
DNA. Once at the PIC, Sub1 interacts with Rpb4/7 via its
C-terminal region (Figures 5 and 8) to keep associated to
RNAPII and chomatin.
SUB1was originally isolated as an allele-specific suppres-
sor of two TFIIBmutations (E62G andR78H) (35), located
within the B-reader region (helix and loop, respectively)
(79). Deletion of SUB1 is synthetically lethal when com-
bined with these two mutations and, in agreement, overex-
pression of SUB1 is required for suppression of their cold
sensitive phenotypes (35). Moreover, a specific interaction
between Sub1 and TFIIB has also been described (35); and
TFIIB is required for Sub1 recruitment to the promoters of
constitutively transcribed genes (78).
Sub1 was subsequently identified as a PIC component
(36). In this elegant study, ChIP data suggest that Sub1
mainly localizes to the promoter region of active genes in a
manner dependent uponTBP.Additionally, FeBABE cleav-
age experiments indicate that Sub1 is located near the lead-
ing edge of the HIS4 transcription bubble, which is also
close to the TFIIB-linker helix (79,80). This is in agreement
with a direct interaction between Sub1 and TFIIB (35).
They proposed a model where Sub1 is first recruited to the
PIC by protein interactions, likely with TFIIB, and at that
point both factors would cooperate in promoter melting.
Then, the interaction of Sub1 withDNAwould stabilize the
open complex, thus promoting transcription initiation and
promoter clearance. Hence, in this model, Sub1, upon pro-
moter melting, can interact with the non-template strand
or perhaps both strands at the upstream junction between
single- and double-stranded DNA. In fact, the residues mu-
tated inTFIIB that specifically interact withSUB1 are in the
B-reader, which has been proposed to act in the capture of
the template strand within the RNAPII active site (79).
Genetic data also suggest that Sub1, once bound to gene
promoters, could help TFIIE and TFIIH to maintain the
PIC in a stable but inactive conformation in the open com-
plex (36). At this point, we propose that Sub1 may inter-
act with Rpb4/7. One hypothesis is that the interaction
is mediated by the carboxy-terminal region of Sub1. The
intrinsically-disordered nature of the Sub1 C-terminal do-
main could allow the protein to span the distance between
the bubble upstream junction and the RNAPII stalk (Fig-
ure 8). This interaction would help to maintain Sub1 asso-
ciated to gene promoters until the next step in transcrip-
tion. Supporting this idea, we identified a specific genetic
interaction between sub1ΔCT and rpb4Δ (Figure 5B), and
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Figure 7. A full length Rpb1-CTD is required for efficient Sub1 association to gene promoters. (A) Genetic interaction between sub1 and rpb1-CTD11.
The sub1Δ deletion increases the slow growth phenotype of rpb1-CTD11 strain at 16, 28 and 37◦C. Serial dilutions (1:10) of wt and mutant strains were
spotted on rich medium and grown for 2–3 days at the indicated temperatures. (B) Chromatin immunoprecipitation (ChIP) analyses were performed using
wt and rpb1-CTD11 strains. Left panel: Rpb3, Rpb4 and Sub1–TAP binding to the promoter (P) of three constitutively expressed genes, PMA1, ADH1
and PGK1, and to the promoter of the IMD2 inducible gene, was examined by qPCR. Results were quantitated (see Material and Methods), and relative
Rpb3, Rpb4 and Sub1–TAP binding in rpb1-CTD11cells is plotted relative to that in wt cells (set equal to 1). Right panel: WCE were prepared from wild-
type (wt) and rpb1-CTD11 strains expressing Sub1–TAP and analyzed by Western blotting using the indicated antibodies. (C) Same as in (B) for wt and
rpb1-CTD20 strains. (D) Left panel: Co-IP performed on WCEs from Sub1–TAP cells (wt and rpb1-CTD11) using an anti-Rpb3 antibody. As a control,
the same amount of cell extract was incubated with Protein A Sepharose alone. Inputs and IPs were analyzed by Western blotting with antibodies to the
indicated proteins. Right panel: Values from the quantification of Sub1-TAP and Rpb3 immunoreactive signals from three experiments were calcuated and
Sub1-TAP/Rpb3 mean ratios were plotted (arbitrary units), where error bars represent standard deviations.
showed that the association of Sub1CTwith gene promot-
ers is significantly reduced in the absence of RPB4 (Figure
5D). In contrast, a mutation altering Sub1 DNA binding
does not affect growth of rpb4Δ mutants (Figure 5D). This
is the first evidence of a role for the CT region of Sub1,
which is not conserved in human PC4, and that also pro-
vides insight into the mechanism used by Sub1 to function
beyond the PIC, later on transcription. Furthermore, this
is also the first demonstration that Sub1 directly interacts
with RNAPII at least through the Rpb4/7 stalk.
Additionally, our data showing a genetic interaction be-
tween SUB1, RPB4 and the RPB1 foot domain (Figure
2A and B), suggest that the function of Sub1 is negative
when the integrity of RNAPII is compromised, such as in
the case of rpb4Δ and rpo21-4 mutants (51). One likely
hypothesis is that Sub1 has a negative role during tran-
scription initiation, repressing transcriptionwhen PIC com-
plexes are not well assembled and/or the integrity of the
polymerase is altered. Therefore, in the rpb4Δ sub1Δ and
rpo21-4 sub1Δ double mutants this repression would be
abolished, enabling RNAPII to circumvent initiation de-
fects due to rpb4Δ (81) and rpo21-4 (51), allowing better cell
growth (Figure 2A and B). On the other hand, and in agree-
ment with this idea, overexpression of SUB1 significantly
aggravates rpb4Δ growth (Figure 2A). Our genetic data are
also consistent with the proposed models for Sub1 function
helping to maintain a stable PIC conformation (25,36), and
its putative localization within the RNAPII-DNA complex
at the initiation step (Figure 8).
In summary, our data and that of others (35,36,50) allow
us to propose a model of Sub1 within the initiation com-
plex (Figure 8). Sub1 binds DNA through its N-terminal
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Figure 8. Schematic model showing the hypothetical localization of Sub1
during transcription initiation. Sub1 is bound to the promoter by inter-
acting with upstream DNA at the junction between single- and double-
stranded DNA (36) through its DNA Binding Domain (Sub1 DBD) (Fig-
ure 5). The proposed localization of Sub1 in this model explains the re-
ported physical (solid arrow) and genetic (dashed arrow) interaction of
Sub1 with TFIIB (35,50). The intrinsically-disordered C-terminal domain
of Sub1 (Sub1 CT) may extend to directly interact with the Rpb4/7 het-
erodimer, as suggested by the specific genetic interaction between this do-
main and RPB4 (Figure 5), and the physical direct interaction with Rpb7
(Figure 4). The genetic interaction between Sub1 and Rpb1 clamp (Fig-
ure 2C) is also illustrated. In addition, the model shows the connections of
Fcp1 phosphatase with Rpb4 and Sub1 revealed by our genetic (Allepuz-
Fuster et al., Calvo &Manley, 2005) and CoIP assays (Figure 6), and con-
sistent with the structural data (76). Our proposed model suggests that
Sub1 may influence Rpb1-CTD phosphorylation (25) and Rpb1 clamp
functionality through its interaction with Rpb4/7, which could also ex-
plain the already suggested role of Sub1 both during transcription initia-
tion (36,37) and elongation (38).
DBD,while is stablymaintained in theRNAPII-DNAcom-
plex by binding to Rpb4/7 via its CT region (Figure 8). As-
sociation of Sub1 with Fcp1 explains the role of Sub1 in
the modulation of CTD phosphorylation during the entire
transcription cycle (25). Our results here strongly suggest
that Sub1 directly interacts with Rpb7, while Fcp1 inter-
acts with Rpb4 to modulate RNAPII CTD phosphoryla-
tion (12). In addition, Sub1 interaction with Rpb4/7 and
the Rpb1 clamp domain may help to explain how it may in-
fluence TSS selection (37) and transcription elongation rate
together with Spt5 (38). This is supported by the genetic
interactions between SUB1 deletion and the rpb1-L1397S
mutation localized within the clamp domain (Figure 2C,
and (52), and by the fact that Spt5 associates with Sub1, and
interacts with Rpb4/7 and the Rpb1 clamp domain (64,65).
Our study provides significant information about
RNAPII transcription regulation by Sub1 and Rpb4/7,
and suggests a model that could be very helpful for future
structural and functional studies on RNAPII transcription
machinery.
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